Description | FCCP (Trifluoromethoxy carbonylcyanide phenylhydrazone) is an oxidative phosphorylation (OXPHOS) inhibitor and mitochondrial proton carrier uncoupler. FCCP is often used as an apoptosis inducer. |
In vitro | 方法:大鼠心室肌细胞用 FCCP (10-1000 nM) 处理 1400 sec,使用 Clark Oxygen Electrode 检测细胞耗氧量。结果:添加 FCCP 后,耗氧量明显、立即且呈剂量依赖性增加。[1]方法:大鼠肾上腺髓质嗜铬瘤细胞 PC12 用 FCCP (30 µM) 处理 0.5-2 h,使用 [3H]methionine 检测蛋白质合成速率。结果:FCCP 处理对蛋白质合成率产生了强烈的抑制作用 (68%),持续处理至少 2 小时。[2] |
In vivo | 方法:为检测对中风的影响,将 FCCP (1 mg/kg) 腹腔注射给中风的 C57BL/6J 小鼠模型,然后进行一小时的短暂性大脑中动脉闭塞 (tMCAO)。结果:用 FCCP 预处理的小鼠皮层、纹状体和全半球的梗死体积显著增加。与载体相比,接受 FCCP 的小鼠具有显著增加的神经功能缺损评分。[3]方法:为检测体内抗肿瘤活性,将 FCCP (1 mg/kg) 和 cisplatin (2 mg/kg) 腹腔注射给携带小鼠卵巢上皮癌肿瘤 ID8 的 C57BL/6 小鼠,每两天一次,持续两周。结果:FCCP 与 cisplatin 联合通过 OMA1 诱导线粒体和 ER 应激来抑制肿瘤生长。[4] |
Cell experiments | Protein synthesis rate is assayed in 24-mm diameter multi-well dishes with fresh medium containing 0.175 Ci/mmol of [3H]methionine (200 μM), for 30 min at 37°C. PC12 cells are treated with FCCP for different period of times. (Only for Reference) |
Synonyms | Carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone, Trifluoromethoxy carbonylcyanide phenylhydrazone |
molecular weight | 254.17 |
Molecular formula | C10H5F3N4O |
CAS | 370-86-5 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
Solubility | DMSO: 55 mg/mL (216.39 mM) |
References | 1. Brennan JP, et al. FCCP is cardioprotective at concentrations that cause mitochondrial oxidation without detectable depolarisation. Cardiovasc Res. 2006 Nov 1;72(2):322-30. 2. Muñoz F, et al. Carbonyl cyanide p-trifluoromethoxyphenylhydrazone (FCCP) induces initiation factor 2 alpha phosphorylation and translation inhibition in PC12 cells. FEBS Lett. 2001 Mar 9;492(1-2):156-9. 3. Grasmick KA, et al. Uncoupling of the Electron Transport Chain Compromises Mitochondrial Oxidative Phosphorylation and Exacerbates Stroke Outcomes. J Neuroinfect Dis. 2018;9(4):283. 4. Cheng M, et al. The Mitochondrial PHB2/OMA1/DELE1 Pathway Cooperates with Endoplasmic Reticulum Stress to Facilitate the Response to Chemotherapeutics in Ovarian Cancer. Int J Mol Sci. 2022 Jan 25;23(3):1320. |
Citations | 1. Liu H, Sun Y, Xu H, et al. PTEN-induced putative kinase 1 regulates mitochondrial quality control and is essential for the maturation of human induced pluripotent stem cell-derived cardiomyocytes. Genes & Diseases. 2022 2. Liang S, Zhu C, Suo C, et al. Mitochondrion-Localized SND1 Promotes Mitophagy and Liver Cancer Progression Through PGAM5. Frontiers in Oncology. 2022, 12: 857968-857968 3. Shi J, Zhang F, Chen L, et al. Systemic mitochondrial disruption is a key event in the toxicity of bacterial pore‐forming toxins to Caenorhabditis elegans. Environmental Microbiology. 2021 Sep;23(9):4896-4907 4. Zheng B X, Long W, Zheng W, et al.Mitochondria-Selective Dicationic Small-Molecule Ligand Targeting G-Quadruplex Structures for Human Colorectal Cancer Therapy.Journal of Medicinal Chemistry.2024 5. Jiang Z.SLC25A19 is required for NADH homeostasis and mitochondrial respiration.Free Radical Biology and Medicine.2024 |